Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola

Robert J Nutt,1 John L Clements,2 William H Dean3 1Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK; 2Boa Vista Eye Clinic, Benguela, Angola; 3Bristol Eye Hospital, Bristol, UK Background: Ocular surface squamous neoplasia (OSSN) is becoming increasingly prevalent and aggressi...

Full description

Bibliographic Details
Main Authors: Nutt RJ, Clements JL, Dean WH
Format: Article
Language:English
Published: Dove Medical Press 2014-12-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/ocular-surface-squamous-neoplasia-in-hiv-positive-and-hiv-negative-pat-peer-reviewed-article-OPTH
id doaj-2235e2cff62f4d1ab8436a88a01e5cdb
record_format Article
spelling doaj-2235e2cff62f4d1ab8436a88a01e5cdb2020-11-24T23:20:53ZengDove Medical PressClinical Ophthalmology1177-54832014-12-012014default2435244019354Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in AngolaNutt RJClements JLDean WH Robert J Nutt,1 John L Clements,2 William H Dean3 1Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK; 2Boa Vista Eye Clinic, Benguela, Angola; 3Bristol Eye Hospital, Bristol, UK Background: Ocular surface squamous neoplasia (OSSN) is becoming increasingly prevalent and aggressive in Sub-Saharan Africa. It is a phenomenon linked with human immunodeficiency virus (HIV) infection, although association rates in Angola are currently unknown. A topical treatment that is effective in HIV-positive and HIV-negative individuals may be preferable to surgery in some contexts. We aimed to estimate the proportion of OSSN associated with HIV in Angola and to report on the success of topical 5-fluorouracil as a primary treatment in HIV-positive and HIV-negative patients.Methods: Photographs of OSSNs taken at presentation and following treatment with 5-fluorouracil in patients presenting to Boa Vista Eye Clinic, Angola, between October 2011 and July 2013 were grouped into HIV-positive and HIV-negative groups and analyzed to compare presenting features and treatment response. Eighty-one OSSNs were analyzed for clinical features and 24 met the inclusion criteria for analysis of treatment response.Results: Eighty-two patients presented with OSSN between October 2011 and July 2013. Twenty-one (26%) were HIV-positive and typically had OSSNs that exhibited more pathological features than those in HIV-negative patients. Twenty-four (29%) patients met the inclusion criteria for analysis of treatment response; of these, 26 (91%) OSSNs in both groups displayed at least partial resolution after one treatment course. In the HIV-positive group, five of eight patients displayed complete resolution, two showed partial resolution, and one failed. In the HIV-negative group, five of 16 showed complete resolution, ten of 16 had partial resolution, and one failed.Conclusion: Individuals presenting with OSSN in Angola are more likely to have HIV infection compared with the general population. Regardless of HIV status, 5-fluorouracil drops can be an effective strategy for management of OSSN without incurring the costs and risks of surgery in the developing world setting. Keywords: ocular surface squamous neoplasia, 5-fluorouracil, Angola, Sub-Saharan Africahttp://www.dovepress.com/ocular-surface-squamous-neoplasia-in-hiv-positive-and-hiv-negative-pat-peer-reviewed-article-OPTH
collection DOAJ
language English
format Article
sources DOAJ
author Nutt RJ
Clements JL
Dean WH
spellingShingle Nutt RJ
Clements JL
Dean WH
Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
Clinical Ophthalmology
author_facet Nutt RJ
Clements JL
Dean WH
author_sort Nutt RJ
title Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
title_short Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
title_full Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
title_fullStr Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
title_full_unstemmed Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola
title_sort ocular surface squamous neoplasia in hiv-positive and hiv-negative patients and response to 5-fluorouracil in angola
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2014-12-01
description Robert J Nutt,1 John L Clements,2 William H Dean3 1Faculty of Medicine and Dentistry, University of Bristol, Bristol, UK; 2Boa Vista Eye Clinic, Benguela, Angola; 3Bristol Eye Hospital, Bristol, UK Background: Ocular surface squamous neoplasia (OSSN) is becoming increasingly prevalent and aggressive in Sub-Saharan Africa. It is a phenomenon linked with human immunodeficiency virus (HIV) infection, although association rates in Angola are currently unknown. A topical treatment that is effective in HIV-positive and HIV-negative individuals may be preferable to surgery in some contexts. We aimed to estimate the proportion of OSSN associated with HIV in Angola and to report on the success of topical 5-fluorouracil as a primary treatment in HIV-positive and HIV-negative patients.Methods: Photographs of OSSNs taken at presentation and following treatment with 5-fluorouracil in patients presenting to Boa Vista Eye Clinic, Angola, between October 2011 and July 2013 were grouped into HIV-positive and HIV-negative groups and analyzed to compare presenting features and treatment response. Eighty-one OSSNs were analyzed for clinical features and 24 met the inclusion criteria for analysis of treatment response.Results: Eighty-two patients presented with OSSN between October 2011 and July 2013. Twenty-one (26%) were HIV-positive and typically had OSSNs that exhibited more pathological features than those in HIV-negative patients. Twenty-four (29%) patients met the inclusion criteria for analysis of treatment response; of these, 26 (91%) OSSNs in both groups displayed at least partial resolution after one treatment course. In the HIV-positive group, five of eight patients displayed complete resolution, two showed partial resolution, and one failed. In the HIV-negative group, five of 16 showed complete resolution, ten of 16 had partial resolution, and one failed.Conclusion: Individuals presenting with OSSN in Angola are more likely to have HIV infection compared with the general population. Regardless of HIV status, 5-fluorouracil drops can be an effective strategy for management of OSSN without incurring the costs and risks of surgery in the developing world setting. Keywords: ocular surface squamous neoplasia, 5-fluorouracil, Angola, Sub-Saharan Africa
url http://www.dovepress.com/ocular-surface-squamous-neoplasia-in-hiv-positive-and-hiv-negative-pat-peer-reviewed-article-OPTH
work_keys_str_mv AT nuttrj ocularsurfacesquamousneoplasiainhivpositiveandhivnegativepatientsandresponseto5fluorouracilinangola
AT clementsjl ocularsurfacesquamousneoplasiainhivpositiveandhivnegativepatientsandresponseto5fluorouracilinangola
AT deanwh ocularsurfacesquamousneoplasiainhivpositiveandhivnegativepatientsandresponseto5fluorouracilinangola
_version_ 1725573806938914816